REQUEST A DEMO
Total
USD $0.00
Search more companies

Phil Pharmawealth, Inc. (Philippines)

Main Activities: Pharmaceutical Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Phil Pharmawealth, Inc. Profile Updated: December 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Phil Pharmawealth, Inc. is based in Philippines. The head office is in Pasig City. It operates in the Pharmaceutical Preparation Manufacturing industry. Phil Pharmawealth, Inc. was incorporated on February 10, 1993. 36 (2023) employees currently work for Phil Pharmawealth, Inc.. From the latest financial highlights, Phil Pharmawealth, Inc. reported a net sales revenue increase of 0.55% in 2024. A growth of 11.67% was recorded in its total assets. The net profit margin of Phil Pharmawealth, Inc. increased by 0.2% in 2024.

Headquarters
Suite 3001, 30Th Floor, Tektite East Tower, Pse Center, Exchange Road, Ortigas Center
Pasig City;

Contact Details: Purchase the Phil Pharmawealth, Inc. report to view the information.

Basic Information
Total Employees:
Purchase the Phil Pharmawealth, Inc. report to view the information.
Financial Auditors:
Purchase the Phil Pharmawealth, Inc. report to view the information.
Incorporation Date:
February 10, 1993
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
48.76%
Purchase this report to view the information.
47.8%
Purchase this report to view the information.
3.44%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Singapore Pharma Wealth Lifesciences, Inc.
Company Performance
Financial values in the chart are available after Phil Pharmawealth, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
0.55%
Total operating revenue
0.32%
Operating profit (EBIT)
36.59%
EBITDA
41.78%
Net Profit (Loss) for the Period
6.39%
Total Assets
11.67%
Total Equity
15.28%
Operating Profit Margin (ROS)
2.03%
Net Profit Margin
0.2%
Return on Equity (ROE)
-1.11%
Debt/Equity
7.96%
Quick Ratio
0.03%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?